Publications

Check Out What’s Happening at Proteocyte.

Select Publications

1. Hwang, J.T.K., Dammling, C., McCord, C. et al. External Validation of Straticyte™, a Quantitative Biomarker-Based Risk Assay in Predicting Oral Cancer. J. Maxillofac. Oral Surg. (2024). https://doi.org/10.1007/s12663-024-02362-7
2. Chi Tonglien Viet, Michael Zhang, Neeraja Dharmaraj, Grace Y Li, Alexander T Pearson, Victoria A Manon, Anupama Grandhi, Ke Xu, Bradley E Aouizerat, Simon Young, Artificial Intelligence Applications in Oral Cancer and Oral Dysplasia, Tissue Engineering Part A, 10.1089/ten.TEA.2024.0096, (2024)
3. Razwia Fathima, Raghini Ramamoorthi, Sivakumar Gopalakrishnan, Vijayashree P. Jayaseelan, Sivakumar Muniapillai, Expression of salivary levels of S100A7 in oral submucous fibrosis and oral leukoplakia, Journal of Oral and Maxillofacial Pathology, 10.4103/jomfp.jomfp_113_23, 28, 1, (84-89), (2024).
4. Kiran Kumar Reddi, Weiqiang Zhang, Shokoufeh Shahrabi-Farahani, Kenneth Mark Anderson, Mingyue Liu, David Kakhniashvili, Xusheng Wang, Yanhui H. Zhang, Tetraspanin CD82 Correlates with and May Regulate S100A7 Expression in Oral Cancer, International Journal of Molecular Sciences, 10.3390/ijms25052659, 25, 5, (2659), (2024).
5. Darling, MR et al. Assessing Oral Epithelial Dysplasia Risk for Transformation to Cancer: Comparison Between Histologic Grading Systems Versus S100A7 Immunohistochemical Signature-based Grading. 2023. doi: 10.1097/PAI.0000000000001132
6. Renick, B et al. Using an AI-Assisted Subcellular S100A7 Bioprotein Assay to Manage Oral Potentially Malignant Disorders/Pre-Cancers. 2023. Oral Health.
7. Pritzker, KPH et al. Oral Potentially Malignant Disorders (OPMD): What is the Clinical Utility of Dysplasia Grade? 2021. Expert Review of Molecular Diagnostics. doi: 10.1080/14737159.2021.1898949
8. Darling, MR et al. Psoriasin: A New Biomarker in the Identification of Cancer Risk in Oral Lesions. 2018. Oral Health.
9. Hwang, JTK et al. Individualized five-year risk assessment for oral premalignant lesion progression to cancer. 2017. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. doi: 10.1016/j.oooo/2016.11.004
10. Chauhan, SS et al. Prediction of recurrence-free survival using a protein expression-based risk classifier for head and neck cancer. 2015. Oncogenesis. doi: 10.1038/oncsis.2015.7
11. Kaur, J et al. S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia. 2013. Int J Cancer. doi: 10.1002/ijc.28473
12. Tripathi, SC et al. Nuclear S100A7 is associated with poor prognosis in head and neck cancer. 2010. PLoS One. doi: https://dx.doi.org/10.1371/journal.pone.0011939